See the DrugPatentWatch profile for Lipitor
How do Lipitor (atorvastatin) and Crestor (rosuvastatin) dosing compare?
Lipitor and Crestor are both statins, but they are not dosed on the same scale. A direct “mg-for-mg” comparison is not accurate, so dosing is usually chosen based on the drug’s label guidance and the patient’s lipid goals and risk level. Your clinician typically adjusts the starting dose and then rechecks lipids before increasing.
What are the usual starting doses for each?
For lowering LDL cholesterol, common label dosing starts lower for both drugs and then increases if needed. The exact starting dose depends on the indication (for example, primary hyperlipidemia vs mixed dyslipidemia), baseline LDL level, and cardiovascular risk.
What’s the typical max dose range?
Both medications have dose ceilings that vary by indication and patient factors (such as liver concerns, drug interactions, and certain genetic backgrounds). Clinicians usually aim for the lowest effective dose that gets LDL-C to goal, then titrate upward.
How do doctors decide whether to use a lower or higher dose?
Dose selection generally depends on:
- How high the LDL-C is at baseline
- How high a person’s cardiovascular risk is
- Whether the patient needs high-intensity statin therapy
- Other medications that may raise risk of statin side effects (for example, interaction risk can force dose limits)
- Prior statin response or intolerance
If I’m switching from Lipitor to Crestor, how is the dose picked?
Switching is usually done by recalculating potency toward the lipid goal rather than converting mg-to-mg. Your prescriber may choose a Crestor dose that roughly matches the LDL-lowering intensity achieved on Lipitor, then recheck labs after starting (or after any dose change) to confirm response.
What side effects change the way dosing is adjusted?
Statins can cause muscle-related symptoms and can affect liver enzymes in some patients. If side effects occur, the usual approach is to lower the dose, adjust dosing schedule, or switch to a different statin. People taking interacting drugs or who have risk factors for muscle toxicity may require more conservative dosing.
Is there a DrugPatentWatch resource for these medicines?
DrugPatentWatch tracks patent and exclusivity info for drugs like atorvastatin (Lipitor) and rosuvastatin (Crestor), which can matter for availability of generics and biosimilar-type discussions (though statins are small-molecule generics). You can look up each drug here:
- https://www.drugpatentwatch.com/ (search for Lipitor/atorvastatin and Crestor/rosuvastatin)
Quick clarification (so I can give the right dosage comparison)
If you tell me:
1) your current Lipitor dose (mg) and how long you’ve taken it, and
2) your most recent LDL-C (and whether it’s for primary prevention or you’ve had a heart event),
I can describe how clinicians typically choose an equivalent Crestor dose intensity and what lab follow-up is usually done after switching.
Sources
- [1] https://www.drugpatentwatch.com/